Myopia
FDA Rejects Sydnexis Myopia Drug for Kids; Chugai to Buy Renalys for $98M Upfront
FDA; SYD-101; Sydnexis; myopia; pediatric; complete response letter; Chugai; Renalys; acquisition; $98M; ophthalmology
FDA Approves LENZ Therapeutics’ VIZZ Eye Drop for Presbyopia
FDA approval; VIZZ; LENZ Therapeutics; presbyopia; aceclidine; eye drop; near vision
CHMP Recommends Five New Drugs and Reviews Eli Lilly’s Kisunla
CHMP; EMA; new drug approvals; Eli Lilly; Kisunla; biosimilars; hyperphosphatemia; myopia; March 2025; regulatory review